ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 75 filers reported holding ATOSSA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $309,497 | +340.3% | 260,081 | +566.0% | 0.00% | – |
| Q1 2024 | $70,295 | +451.6% | 39,053 | +125.7% | 0.00% | – |
| Q3 2023 | $12,743 | -87.2% | 17,302 | -78.1% | 0.00% | – |
| Q2 2023 | $99,377 | +507.7% | 78,871 | +249.6% | 0.00% | – |
| Q1 2023 | $16,354 | -29.5% | 22,561 | -48.6% | 0.00% | – |
| Q4 2022 | $23,186 | +157.6% | 43,871 | +295.2% | 0.00% | – |
| Q3 2022 | $9,000 | -89.5% | 11,100 | -86.0% | 0.00% | – |
| Q2 2022 | $86,000 | -67.5% | 79,287 | -62.5% | 0.00% | – |
| Q1 2022 | $265,000 | -84.5% | 211,658 | -80.3% | 0.00% | – |
| Q4 2021 | $1,714,000 | -73.1% | 1,072,095 | -45.2% | 0.00% | -100.0% |
| Q3 2021 | $6,377,000 | -81.9% | 1,956,041 | -64.9% | 0.00% | -84.6% |
| Q2 2021 | $35,232,000 | +2148.4% | 5,574,749 | +650.6% | 0.01% | +1200.0% |
| Q1 2021 | $1,567,000 | +6713.0% | 742,710 | +3224.7% | 0.00% | – |
| Q4 2018 | $23,000 | -43.9% | 22,339 | -5.3% | 0.00% | – |
| Q3 2018 | $41,000 | – | 23,592 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 524,805 | $572,000 | 0.39% |
| Laurion Capital Management LP | 2,225,800 | $2,426,000 | 0.04% |
| Ergoteles LLC | 514,600 | $561,000 | 0.02% |
| Pinz Capital Management, LP | 17,900 | $20,000 | 0.01% |
| Alpine Global Management, LLC | 37,089 | $40,000 | 0.01% |
| Game Plan Financial Advisors, LLC | 10,000 | $11,000 | 0.01% |
| Spire Wealth Management | 100,300 | $109,000 | 0.00% |
| Renaissance Technologies | 1,989,995 | $2,169,000 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,279,636 | $2,485,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 16,912 | $18,000 | 0.00% |